A potential health concern has been raised about the new Ozempic and Wegovy pills, which contain a hidden ingredient that might have some unexpected side effects.
The Weight Loss Pill Dilemma: Is It Worth the Risk?
These popular GLP-1 drugs, now available in pill form, have an active ingredient called semaglutide, which has historically been administered through weekly injections. However, due to the needle aversion of many consumers, manufacturers have developed a daily pill version, promising similar results without the needle prick.
But here's where it gets controversial: the pill's effectiveness relies on a compound called salcaprozate sodium (SNAC), which ensures semaglutide survives the stomach's harsh environment. Researchers from the University of Adelaide studied the impact of repeated exposure to SNAC on animal models, and their findings are intriguing.
In a 21-day study, they observed the following changes:
- A decrease in good gut bacteria that breaks down dietary fiber
- Lower levels of short-chain fatty acids, which are crucial for intestinal health and immune function
- Increased inflammatory markers in the blood
- Higher liver weight
- A smaller cecum, which is responsible for fiber breakdown and protective compound production
- Reduced levels of a protein associated with cognitive impairment
Lead author Amin Ariaee, a PhD candidate at Adelaide University, emphasizes the need to understand the long-term effects of all ingredients, not just the active drug, as oral versions become more prevalent.
"While SNAC enables semaglutide to be taken orally, our study suggests it may also disrupt the gut microbiome, elevate inflammation, and impact cognitive-related proteins," Ariaee explains.
While the study doesn't prove SNAC is inherently harmful, it highlights the need for further research. With two new daily pills expected to hit the market soon, it's essential to consider the potential consequences of consistent exposure to SNAC.
Dr. Paul Joyce, a Senior Research Fellow, adds, "These medicines are typically taken daily and for extended periods. As their global use expands, evaluating all components, not just the active compound, becomes crucial."
So, the question remains: Are the potential benefits of these pills worth the possible risks? We invite you to share your thoughts and experiences in the comments below.
[Find more information on safe injectable GLP-1 options and stay tuned for updates on the latest developments.]
Note: New York Post may receive revenue from affiliate and advertising partnerships for sharing this content.
